(Q36733078)

English

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial

scientific article published on 28 February 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Aron Goldhirsch

19

object named as

Aron Goldhirsch

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Manuela Rabaglio

17

object named as

Manuela Rabaglio

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

5

object named as

Karin Ribi

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Graziella Pinotti

10

object named as

Graziella Pinotti

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Diana Crivellari

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kathryn P Gray

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Silvia Dellapasqua

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Fabio Puglisi

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Karen N Price

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

István Láng

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Lorenzo Gianni

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Simon Spazzapan

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jean-Marc Lüthi

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Richard D Gelber

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Meredith M Regan

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Marco Colleoni

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Monica Castiglione-Gertsch

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rudolf Maibach

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Alan S Coates

18

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

International Breast Cancer Study Group

20

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

28 February 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

22

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

130-137

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

Adjuvant chemotherapy in older women with early-stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

The anti-angiogenic basis of metronomic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

30 September 2017

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

28 June 2018

Older Women With Breast Cancer: Slow Progress, Great Opportunity, Now Is the Time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Breast cancer in the elderly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Health related quality of life: a changing construct?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Patients' estimation of overall treatment burden: why not ask the obvious?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

The Mini-Cog: receiver operating characteristics with expert and naïve raters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

5 September 2018

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

4 December 2018

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3613787

4 December 2018

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23453899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/23453899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23453899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23453899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23453899

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BREAST.2013.01.015

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36733078&oldid=1768029931"